ATC-002
Androgenic alopecia
Pre-clinical/Proof-of-ConceptActive
Key Facts
About Atticus Pharma
Atticus Pharma is a private, pre-revenue biotech leveraging its proprietary Z-pods® silica particle technology for sustained, localized drug delivery. Its lead programs target immunodermatology (cutaneous lupus) and androgenic alopecia, with a third exploring topical sildenafil for erectile dysfunction. The company's strategy aims to improve therapeutic efficacy and safety by creating localized drug depots, thereby minimizing systemic exposure and side effects associated with current oral or topical treatments.
View full company profile